Why Australia is a Go-To Destination for Clinical Trials

from The MTPConnect Podcast · host MTPConnect

The MTPConnect Podcast team recently caught up with Pfizer Ventures Managing Partner Dr Barbara Dalton to talk about Australia’s strengths as a destination to conduct clinical trials. Dr Dalton discusses what’s so attractive about Australia to international companies and we explore the potential to grow the export earning potential of our clinical trials ecosystem.

Episode metadata supplied by the publisher feed · Published Aug 28, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Why Australia is a Go-To Destination for Clinical Trials

0:00 11:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The MTPConnect Podcast?

This episode is 11 minutes long.

When was this The MTPConnect Podcast episode published?

This episode was published on August 28, 2019.

Can I download this The MTPConnect Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!